Mario Mercuri

Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy

Gaetano Bacci, Alessandra Longhi, Michela Versari et al. · Cancer · 2006 · 565 citations

Neoadjuvant Chemotherapy With High-Dose Ifosfamide, High-Dose Methotrexate, Cisplatin, and Doxorubicin for Patients With Localized Osteosarcoma of the Extremity: A Joint Study by the Italian and Scandinavian Sarcoma Groups

Stefano Ferrari, Sigbjørn Smeland, Mario Mercuri et al. · Journal of Clinical Oncology · 2005 · 432 citations

Platelet-derived growth factors enhance proliferation of human stromal stem cells

Enrico Lucarelli, Amira Beccheroni, Davide María Donati et al. · Biomaterials · 2003 · 402 citations

Regenerative Medicine, Platelet-derived Growth Factors, Thrombopoiesis +7

Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival

Stefano Ferrari, A Briccoli, Mario Mercuri et al. · Journal of Clinical Oncology · 2003 · 312 citations · Full text

Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin

Gaetano Bacci, Piero Picci, Stefano Ferrari et al. · Cancer · 1993 · 296 citations · Full text